Alkeon Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-204,484
| Closed | -$18.7M | – | 55 |
|
|
2016
Q2 | $18.7M | Sell |
204,484
-99,730
| -33% | -$9.12M | 0.36% | 49 |
|
|
2016
Q1 | $25.1M | Sell |
304,214
-85
| -0% | -$7.01K | 0.52% | 43 |
|
|
2015
Q4 | $31.9M | Hold |
304,299
| – | – | 0.65% | 40 |
|
|
2015
Q3 | $31.1M | Hold |
304,299
| – | – | 0.65% | 41 |
|
|
2015
Q2 | $41.6M | Buy |
304,299
+25,000
| +9% | +$3.42M | 0.81% | 44 |
|
|
2015
Q1 | $34.8M | Sell |
279,299
-446,876
| -62% | -$55.7M | 0.66% | 41 |
|
|
2014
Q4 | $65.6M | Sell |
726,175
-656,600
| -47% | -$59.4M | 1.28% | 33 |
|
|
2014
Q3 | $99.8M | Sell |
1,382,775
-150,000
| -10% | -$10.8M | 1.98% | 21 |
|
|
2014
Q2 | $95.4M | Buy |
1,532,775
+81,275
| +6% | +$5.06M | 1.74% | 24 |
|
|
2014
Q1 | $99M | Buy |
1,451,500
+450,000
| +45% | +$30.7M | 1.67% | 24 |
|
|
2013
Q4 | $70.5M | Buy |
+1,001,500
| New | +$70.5M | 1.19% | 33 |
|